← Back to all clusters

Cluster 95

12 diseases · 21 shared-gene connections
12 Diseases
17 Unique genes
0.243 Avg. similarity score
Branchial arch abnormalities syndrome Most-connected disease (6 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
KMT2D 7 / 12 Branchial arch abnormalities syndrome, Branchial cleft anomalies, Choanal atresia syndrome, Congenital small ears and 3 more
TXNL4A 3 / 12 Burn-mckeown syndrome, Choanal atresia syndrome, choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome
CNOT1 2 / 12 holoprosencephaly 12 with or without pancreatic agenesis, Vissers-bodmer syndrome
EPHB4 2 / 12 EPHB4-associated vascular malformation spectrum, Vein of galen aneurysm
IPO8 2 / 12 Duane-radial ray syndrome, Vissers-bodmer syndrome
POLR1A 2 / 12 Burn-mckeown syndrome, Choanal atresia syndrome
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Breakdown of the nuclear lamina Reactome 1 / 3 235× 4.24e-3 3.93e-2 ✓ sig.
Nuclear Envelope Breakdown Reactome 1 / 9 78.5× 1.27e-2 7.87e-2
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion Reactome 1 / 10 70.6× 1.41e-2 8.38e-2
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation Reactome 1 / 13 54.3× 1.83e-2 9.79e-2
Sema3A PAK dependent Axon repulsion Reactome 1 / 15 47.1× 2.10e-2 1.06e-1
Depolymerisation of the Nuclear Lamina Reactome 1 / 15 47.1× 2.10e-2 1.06e-1
CRMPs in Sema3A signaling Reactome 1 / 16 44.2× 2.24e-2 1.10e-1
Transcriptional regulation of pluripotent stem cells Reactome 1 / 17 41.6× 2.38e-2 1.13e-1
Ephrin signaling Reactome 1 / 19 37.2× 2.66e-2 1.21e-1
Initiation of Nuclear Envelope (NE) Reformation Reactome 1 / 19 37.2× 2.66e-2 1.21e-1
Axon guidance KEGG 2 / 183 7.7× 2.70e-2 1.22e-1
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain Reactome 1 / 20 35.3× 2.80e-2 1.24e-1
Interleukin-37 signaling Reactome 1 / 21 33.6× 2.93e-2 1.27e-1
EPH-Ephrin signaling Reactome 1 / 22 32.1× 3.07e-2 1.31e-1
Regulation of TP53 Activity through Acetylation Reactome 1 / 23 30.7× 3.21e-2 1.34e-1

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
heterochromatin formation GO:0031507 3 / 70 47.1× 3.30e-5 1.31e-3 ✓ sig.
cardiac septum morphogenesis GO:0060411 2 / 16 137× 9.28e-5 2.86e-3 ✓ sig.
pharyngeal system development GO:0060037 2 / 21 105× 1.62e-4 4.34e-3 ✓ sig.
motor neuron axon guidance GO:0008045 2 / 24 91.6× 2.12e-4 5.27e-3 ✓ sig.
positive regulation of transcription by RNA polymerase II GO:0045944 6 / 1,208 5.5× 4.80e-4 9.31e-3 ✓ sig.
negative regulation of cell population proliferation GO:0008285 4 / 444 9.9× 5.85e-4 1.07e-2 ✓ sig.
beta-catenin-TCF complex assembly GO:1904837 1 / 1 1,099× 9.10e-4 1.42e-2 ✓ sig.
right ventricular compact myocardium morphogenesis GO:0003226 1 / 1 1,099× 9.10e-4 1.42e-2 ✓ sig.
rhombomere 3 morphogenesis GO:0021658 1 / 1 1,099× 9.10e-4 1.42e-2 ✓ sig.
tissue development GO:0009888 2 / 51 43.1× 9.67e-4 1.47e-2 ✓ sig.
cellular senescence GO:0090398 2 / 57 38.6× 1.21e-3 1.70e-2 ✓ sig.
pattern specification process GO:0007389 2 / 60 36.6× 1.34e-3 1.79e-2 ✓ sig.
heart morphogenesis GO:0003007 2 / 61 36.0× 1.38e-3 1.84e-2 ✓ sig.
negative regulation of protein localization to nucleolus GO:1904750 1 / 2 550× 1.82e-3 2.15e-2 ✓ sig.
rhombomere 2 development GO:0021568 1 / 2 550× 1.82e-3 2.15e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Burn-mckeown syndrome Choanal atresia syndrome 0.333 2 8.44e-8 6.27e-7 ✓ sig.
Branchial arch abnormalities syndrome kabuki syndrome 1 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Branchial arch abnormalities syndrome Branchial cleft anomalies 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Branchial cleft anomalies kabuki syndrome 1 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Burn-mckeown syndrome choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Branchial cleft anomalies Vissers-bodmer syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Branchial arch abnormalities syndrome Vissers-bodmer syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
holoprosencephaly 12 with or without pancreatic agenesis Vissers-bodmer syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
kabuki syndrome 1 Vissers-bodmer syndrome 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Branchial arch abnormalities syndrome Congenital small ears 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Branchial cleft anomalies Choanal atresia syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Branchial cleft anomalies Congenital small ears 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Branchial arch abnormalities syndrome Choanal atresia syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Choanal atresia syndrome kabuki syndrome 1 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Choanal atresia syndrome choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Congenital small ears kabuki syndrome 1 0.167 1 3.25e-4 7.58e-4 ✓ sig.
Duane-radial ray syndrome Vissers-bodmer syndrome 0.200 1 3.90e-4 8.52e-4 ✓ sig.
EPHB4-associated vascular malformation spectrum Vein of galen aneurysm 0.143 1 3.90e-4 8.52e-4 ✓ sig.
Branchial arch abnormalities syndrome Vein of galen aneurysm 0.143 1 3.90e-4 8.52e-4 ✓ sig.
Branchial cleft anomalies Vein of galen aneurysm 0.143 1 3.90e-4 8.52e-4 ✓ sig.
kabuki syndrome 1 Vein of galen aneurysm 0.143 1 3.90e-4 8.52e-4 ✓ sig.